Biofrontera Inc. (BFRI) Stock Price & Analysis
Biofrontera Inc. (BFRI) fell 2.17% to USD 1.58 as of September 8, 2026 at 14:48 UTC, according to Nexqual real-time market data.
BFRI last closed at USD 1.58; the session ranged USD 1.55–1.66 on volume of 478,270 shares. Market capitalization is —, with a 52-week range of USD 0.56–1.66 (NCM). Source: Nexqual, September 8, 2026 at 14:48 UTC.
Key Statistics (as of September 8, 2026 at 14:48 UTC)
| Price | USD 1.58 |
|---|---|
| Change | ▼ 2.17% (down) |
| Previous Close | USD 1.58 |
| Open | USD 1.58 |
| Day Range | USD 1.55 – 1.66 |
| 52-Week Range | USD 0.56 – 1.66 |
| Volume | 478,270 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (BFRI)
Nexqual's technical model rates BFRI "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of September 8, 2026 at 14:48 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 67.43 (neutral) |
| vs SMA50 | Above (USD 1.25) |
| MACD | 0.1 (positive) |
From Biofrontera Inc.'s Latest SEC 10-K Filing (filed 2026-03-19)
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PTPI | Petros Pharmaceuticals, Inc. | USD 0.01 | ▲ 60% |
| ISPC | iSpecimen Inc. | USD 1.75 | ▲ 13.64% |
| LGVN | Longeveron Inc. | USD 6.67 | ▲ 1.37% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.44 | ▼ 0.57% |
| KTTA | Pasithea Therapeutics Corp. | USD 0.59 | ▲ 2.24% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 14:48 UTC. This page is informational and not investment advice.